BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260521T190000
DTEND;TZID=Africa/Nairobi:20260521T203000
DTSTAMP:20260526T215031
CREATED:20260525T210458Z
LAST-MODIFIED:20260525T210536Z
UID:41677-1779390000-1779395400@kesho-kenya.org
SUMMARY:Bladder Cancer Care
DESCRIPTION:SPEAKERS: Dr. Patrick Mbuthia\, Dr. Helena Musau\, Dr Mohammed Ezzi\nDate: 21st May 2026\nModerator: Dr. Sitna Mwanzi \nThis session examined bladder cancer through a multidisciplinary lens\, bringing together surgical\, radiotherapeutic and systemic treatment perspectives across the continuum of care. \nA central theme was the need for accurate staging and risk-adapted management. Dr. Patrick Mbuthia discussed the role of transurethral resection of bladder tumour (TURBT) in diagnosis\, staging and treatment\, particularly for non-muscle invasive disease. The importance of complete resection\, adequate detrusor muscle in the specimen\, careful imaging and attention to complications was emphasized as central to subsequent treatment decisions. \nDr. Helena Musau highlighted the evolving role of radiotherapy in bladder preservation\, especially through tri-modality therapy combining maximal TURBT\, concurrent chemoradiation and structured response assessment. The discussion also addressed patient selection\, surveillance\, salvage options\, palliative radiotherapy for symptoms\, and the value of newer radiotherapy techniques in reducing toxicity while preserving quality of life. \nDr. Mohammed Ezzi reviewed systemic treatment across non-muscle invasive\, muscle invasive and metastatic bladder cancer. He outlined the role of intravesical therapy\, BCG\, cisplatin eligibility\, immunotherapy\, maintenance strategies and emerging options such as antibody-drug conjugates and targeted agents\, while noting that cost and availability continue to shape real-world treatment in Kenya. \nAcross the session\, a consistent message emerged: improving bladder cancer outcomes requires timely diagnosis\, high-quality TURBT\, multidisciplinary decision-making and treatment pathways that reflect both evidence and local access reality. \nKey Takeaways \n\nBladder cancer management depends on accurate staging and distinction between non-muscle invasive and muscle invasive disease.\nHigh-quality TURBT with adequate muscle sampling is central to diagnosis and treatment planning.\nTrimodality therapy offers bladder preservation for carefully selected patients.\nSystemic therapy is rapidly evolving with immunotherapy\, maintenance approaches and antibody-drug conjugates.\nLocal data are needed to address African patterns of disease\, including schistosomiasis-associated squamous cell carcinoma.\n\n 
URL:https://kesho-kenya.org/event/bladder-cancer-care/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/05/Bladder-Cancer-Care.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260528T190000
DTEND;TZID=Africa/Nairobi:20260528T203000
DTSTAMP:20260526T215031
CREATED:20260525T190142Z
LAST-MODIFIED:20260526T114254Z
UID:41658-1779994800-1780000200@kesho-kenya.org
SUMMARY:Advancing Care Through Multidisciplinary Collaboration
DESCRIPTION:The Brain Tumour JourneyAdvancing Care Through Multidisciplinary Collaboration \nDate: 28th May 2026Time: 7 PM – 8:30 PM EATwww.kesho-kenya.org \nSpeakers & Topics\nDr. Michael MagohaConsultant Neurological Surgeon & Lecturer\, University of Nairobi\, Co-Founder Brain Tumor Association of KenyaThe Beginning of the Brain Tumor Journey – A Neurosurgeon’s Perspective \nDr. Sarah MumaPaediatric Haemato-Oncologist\, Kenyatta National HospitalMultidisciplinary Management of Brain Tumors: Optimizing Outcomes Through Collaborative Care \nParmenas Minda OkwemaSenior Lecturer\, Department of Human Pathology\, University of Nairobi\, Chairman and Founder\, Brain Tumor Association of KenyaUnderstanding Brain Tumour Diagnosis: Pathology Principles and Diagnostic Challenges \nRN Celine KilanyaPaediatric Oncology Nurse\, Kenyatta National HospitalHolistic and Supportive Care in Brain Tumour Management: The Oncology Nurse’s Role in Patient Navigation \nMr. David L. Oluoch-Olunya (Moderator)Consultant Neurological Surgeon\, The Nairobi Hospital & Senior Lecturer\, Aga Khan University Hospital \n    	\n        CLICK TO REGISTER
URL:https://kesho-kenya.org/event/advancing-care-through-multidisciplinary-collaboration/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/05/WhatsApp-Image-2026-05-26-at-8.18.55-AM.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20261119T080000
DTEND;TZID=Africa/Nairobi:20261121T170000
DTSTAMP:20260526T215031
CREATED:20260407T183641Z
LAST-MODIFIED:20260519T095620Z
UID:41566-1795075200-1795280400@kesho-kenya.org
SUMMARY:The 9th Kenya International Cancer Conference
DESCRIPTION:
URL:https://kesho-kenya.org/event/2026-kenya-international-cancer-conference/
CATEGORIES:Conferences,Webinar Recording Available
END:VEVENT
END:VCALENDAR